BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21998422)

  • 1. Comparative performance of human papillomavirus DNA testing using novel sample collection methods.
    Gage JC; Partridge EE; Rausa A; Gravitt PE; Wacholder S; Schiffman M; Scarinci I; Castle PE
    J Clin Microbiol; 2011 Dec; 49(12):4185-9. PubMed ID: 21998422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples.
    Jentschke M; Soergel P; Hillemanns P
    J Virol Methods; 2013 Oct; 193(1):131-4. PubMed ID: 23707925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of screening performance of HPV DNA test on specimens from different sites of the female genital tract].
    Zhang S; Kang L; Liu B; Cui J; Chen F; Liu X; Wang H; Chen W
    Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):389-93. PubMed ID: 25030599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of three commercial systems for detection of high-risk human papillomavirus in cervical and vaginal ThinPrep PreservCyt samples and correlation with biopsy results.
    Binnicker MJ; Pritt BS; Duresko BJ; Espy MJ; Grys TE; Zarka MA; Kerr SE; Henry MR
    J Clin Microbiol; 2014 Oct; 52(10):3763-8. PubMed ID: 25122861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of ThermoFisher's Papspin for human papillomavirus detection in cervicovaginal specimens using PCR with GP5+/GP6+ primers and the Hybrid Capture II assay.
    Weynand B; Delvenne P; Polet R; Guiot Y; Arafa M; Somja J; Galant C
    Clin Microbiol Infect; 2010 Jun; 16(6):671-5. PubMed ID: 19689463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of human papillomavirus detection by Abbott m2000 system on samples collected by FTA Elute™ Card in a Chinese HIV-1 positive population.
    Qin Y; Zhang H; Marlowe N; Fei M; Yu J; Lei X; Yu L; Zhang J; Cao D; Ma L; Chen W
    J Clin Virol; 2016 Dec; 85():80-85. PubMed ID: 27846440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The concordance of HPV DNA detection by Hybrid Capture 2 and careHPV on clinician- and self-collected specimens.
    Chen W; Jeronimo J; Zhao FH; Qiao YL; Valdez M; Zhang X; Kang LN; Bansil P; Paul P; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
    J Clin Virol; 2014 Dec; 61(4):553-7. PubMed ID: 25453572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-collected versus clinician-collected cervical samples for the detection of HPV infections by 14-type DNA and 7-type mRNA tests.
    Aranda Flores CE; Gomez Gutierrez G; Ortiz Leon JM; Cruz Rodriguez D; Sørbye SW
    BMC Infect Dis; 2021 May; 21(1):504. PubMed ID: 34058992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of INNO-LiPA genotyping extra and hybrid capture 2 assays for detection of carcinogenic human papillomavirus genotypes.
    Barzon L; Militello V; Pagni S; Palù G
    J Clin Virol; 2012 Nov; 55(3):256-61. PubMed ID: 22877561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
    Del Pino M; Alonso I; Rodriguez-Trujillo A; Bernal S; Geraets D; Guimerà N; Torne A; Ordi J
    J Virol Methods; 2017 Oct; 248():238-243. PubMed ID: 28739302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the hybrid capture 2 and cobas 4800 tests for detection of high-risk human papillomavirus in specimens collected in PreservCyt medium.
    Wong AA; Fuller J; Pabbaraju K; Wong S; Zahariadis G
    J Clin Microbiol; 2012 Jan; 50(1):25-9. PubMed ID: 22090403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical Human Papillomavirus Testing With Two Home Self-Collection Methods Compared With a Standard Clinically Collected Sampling Method.
    McLarty JW; Williams DL; Loyd S; Hagensee ME
    Sex Transm Dis; 2019 Oct; 46(10):670-675. PubMed ID: 31517806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of a New Lower-Cost Real-Time PCR Assay for Detection of High-Risk Human Papillomavirus: Useful for Cervical Screening in Limited-Resource Settings?
    Fokom Domgue J; Schiffman M; Wentzensen NH; Gage JC; Castle PE; Raine-Bennett TR; Fetterman B; Lorey T; Poitras NE; Befano B; Xie Y; Miachon LS; Dean M
    J Clin Microbiol; 2017 Aug; 55(8):2348-2355. PubMed ID: 28515214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
    Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
    J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct comparison of two vaginal self-sampling devices for the detection of human papillomavirus infections.
    Jentschke M; Chen K; Arbyn M; Hertel B; Noskowicz M; Soergel P; Hillemanns P
    J Clin Virol; 2016 Sep; 82():46-50. PubMed ID: 27434147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field Evaluation of Xpert HPV Point-of-Care Test for Detection of Human Papillomavirus Infection by Use of Self-Collected Vaginal and Clinician-Collected Cervical Specimens.
    Toliman P; Badman SG; Gabuzzi J; Silim S; Forereme L; Kumbia A; Kombuk B; Kombati Z; Allan J; Munnull G; Ryan C; Vallely LM; Kelly-Hanku A; Wand H; Mola GDL; Guy R; Siba P; Kaldor JM; Tabrizi SN; Vallely AJ
    J Clin Microbiol; 2016 Jul; 54(7):1734-1737. PubMed ID: 27076663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk HPV detection in specimens collected in SurePath preservative fluid: comparison of ambient and refrigerated storage.
    Hardie A; Moore C; Patnick J; Cuschieri K; Graham C; Beadling C; Ellis K; Frew V; Cubie HA
    Cytopathology; 2009 Aug; 20(4):235-41. PubMed ID: 19659956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting.
    Carozzi FM; Burroni E; Bisanzi S; Puliti D; Confortini M; Giorgi Rossi P; Sani C; Scalisi A; Chini F
    J Clin Microbiol; 2011 Apr; 49(4):1446-51. PubMed ID: 21325553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of PapType to Digene Hybrid Capture 2, Roche linear array, and Amplicor for detection of high-risk human papillomavirus genotypes in women with previous abnormal pap smears.
    Tabrizi SN; Stevens MP; Khan ZA; Chow C; Devitt MA; Garland SM
    J Clin Microbiol; 2012 Aug; 50(8):2796-8. PubMed ID: 22649012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.